Outpatient group therapy for post-COVID patients - a naturalistic feasibility study of a face-to-face and online group concept.
Zimmermann-Schlegel, Verena, Gronewold, Nadine, Stengel, Sandra et al. · Frontiers in psychiatry · 2024 · DOI
Quick Summary
Researchers created and tested a group therapy program for people with Post-COVID syndrome that meets weekly for 8 sessions to help manage fatigue, stress sensitivity, and other symptoms. The program was offered both in-person and online to 57 patients, and most participants found it helpful, especially valuing the chance to connect with others experiencing similar challenges. The results suggest this type of group therapy is safe and acceptable, with the online format being particularly useful for people who have difficulty leaving home.
Why It Matters
This study addresses a critical gap in Post-COVID care by developing a low-burden, accessible intervention for patients with severe mobility limitations—a challenge directly relevant to ME/CFS populations who experience post-exertional malaise. The emphasis on online delivery and peer support reflects realistic barriers faced by severely affected patients, and demonstrates that structured psychoeducational group intervention can be safely delivered in this vulnerable population.
Observed Findings
57 patients with Post-COVID syndrome participated (36 online, 21 face-to-face), most with severe functional limitations.
Both face-to-face and online formats were accepted and requested by participants.
Participants predominantly rated the group therapy as beneficial.
Peer support and shared experience with others facing similar challenges were identified as particularly valuable.
The interprofessional, integrative approach addressing fatigue, stress intolerance, and coping strategies was rated as safe and helpful.
Inferred Conclusions
Group-based psychoeducational therapy is a feasible, safe, and acceptable intervention for Post-COVID patients with significant functional limitations.
Online delivery formats are appropriate and potentially superior for patients with mobility restrictions due to Post-COVID syndrome.
Peer connection and shared validation within group settings may be key therapeutic components for Post-COVID populations.
Interprofessional, integrative approaches targeting symptom management and coping may warrant further evaluation in controlled trials.
Remaining Questions
Does group therapy produce sustained symptom improvement compared to standard care or waitlist control?
What This Study Does Not Prove
This feasibility study does not prove that group therapy improves Post-COVID symptoms or outcomes compared to no treatment, as there was no control group. It demonstrates acceptability and perceived helpfulness only, not objective clinical benefit. The cross-sectional nature and reliance on questionnaires cannot establish whether symptom improvement persisted beyond the intervention period or what specific components drove perceived benefit.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →